The looming threat of fake weight-loss pills: A warning for Britain's health and safety.
Experts are raising the alarm about a potential flood of counterfeit weight-loss treatments in tablet form, a worrying development as pharmaceutical companies prepare to launch oral versions of these medications, currently only available via injections in the UK.
But here's where it gets controversial: while pill forms are expected to be cheaper and more accessible, they also present an easier target for fraudsters. Professor Bhavik Patel from the University of Brighton warns that "pills are much easier prey for scammers." With relatively simple equipment, fraudsters can produce vast quantities of counterfeit pills, posing a significant risk to public health.
In the UK, the demand for weight-loss jabs like Wegovy and Mounjaro has been growing, with impressive results shown in trials. However, these jabs are expensive, require special equipment, and must be stored under specific conditions. Now, pharmaceutical companies are developing oral alternatives, creating tablets that mimic the hormone GLP-1.
And this is the part most people miss: the potential for counterfeits to slip through the cracks. Dr. Bernard Naughton, an associate professor at Trinity College Dublin, highlights the risks. Counterfeit pills could be made from medications diverted from the legitimate supply chain, potentially stored incorrectly, or even contaminated. They may contain incorrect doses, the wrong active ingredient, or no active ingredient at all.
"We've already seen examples of falsified injections," Naughton warns. "It's easy to create a pill and pass it off as the real deal with good packaging." His research suggests people are more willing to take risks with tablets than injections, even when they suspect something might be amiss.
Novo Nordisk, the producer of Wegovy, emphasizes that their pill contains not only the active ingredient semaglutide but also SNAC (salcaprozate sodium), which enhances drug absorption. "Only Novo Nordisk manufactures FDA-approved semaglutide medicines with this SNAC technology," they state, warning against compounded semaglutide, which is not FDA-approved and may contain impurities or untested doses.
The MHRA has issued repeated warnings about the importance of buying jabs from registered pharmacies or legitimate retailers, as fake weight-loss medications are not a new phenomenon. Associate Professor Oksana Pyzik from the UCL School of Pharmacy notes that demand has outpaced regulated supply, and price rises have driven some to seek cheaper alternatives online via unlicensed routes.
"Oral weight-loss drugs may improve access, but they also widen the opportunity for criminals to falsify GLP-1s," Pyzik says. The MHRA's raid on a factory in Northampton last year, seizing counterfeit weight-loss jabs worth over £250,000, highlights the scale of the problem. However, the investigation is ongoing, and the company whose name appeared on the packaging continues to advertise on Telegram, showing the challenges in regulating online sales.
Patel believes the MHRA is proactive, but the use of social media and online marketplaces poses a significant risk. "With the huge demand for pills, the UK Border Force and MHRA will be stretched. We may not be able to eradicate counterfeit products entirely," he cautions.
Eli Lilly and Novo Nordisk are taking action to combat counterfeits, including online monitoring, sharing information with authorities, and providing sample pills for testing. Andy Morling, deputy director of enforcement at the MHRA, emphasizes the rigorous standards medicines must meet before authorization in the UK. "Any medicine supplied illegally poses a risk to public health and patient safety," he states.
Pyzik, academic chair of the Fight the Fakes Alliance, calls for stronger regulation and enforcement, highlighting the UK's use of AI tools to detect falsified online adverts. "Patients should only access these products with a prescription and under medical supervision. Social media purchases are risky," she advises.
Naughton suggests the UK should make it easier for patients to verify legitimate online pharmacies and develop public health campaigns targeting different risk attitudes. "Buying medicines online has value, providing access to many who wouldn't otherwise have it," he adds.
This issue is a complex web of accessibility, health risks, and criminal activity. What are your thoughts? Do you think the potential benefits of oral weight-loss drugs outweigh the risks of counterfeits? Or should we prioritize stricter regulations and enforcement to protect public health? We'd love to hear your opinions in the comments!
